BACKGROUND The treatment of hepatocellular carcinoma (HCC) is still a major health issue because of its increasing incidence and because of the complexity of its management. Transarterial embolization (TAE) and transarterial chemoembolization (TACE) are two widely used locoregional therapies in the treatment of HCC, especially for unresectable intermediate and advanced HCCs. SUMMARY The moder...

objectives this study aimed to evaluate the safety and effectiveness of transarterial ethanol ablation (tea) for the treatment of hcc with pvtt. methods patients were treated with tea for pvtt under cone-beam computed tomography and traditional transarterial chemoembolization (tace) with epirubicin for intrahepatic lesions. results seventeen men were successfully treated with tace plus tea. the...

AIM To evaluate the feasibility of the McA-RH7777 tumor model in Sprague-Dawley (SD) rats, for study of hepatoma and transarterial chemoembolization. MATERIALS AND METHODS McA-RH7777 rat hepatoma cells (1×10(7)) were inoculated into the left hepatic lobe of SD rats (n=38). Chemoembolization with left common carotid artery access was performed using an emulsion of iodized oil and doxorubicin, ...

BACKGROUND There is no standard therapeutic procedure for the hepatocellular carcinoma (HCC) in patients with poor hepatic reserve function. With the approval of newly developed chemotherapeutic agent of miriplatin, we have firstly conducted the phase I study of CDDP powder (DDP-H) and miriplatin combination therapy and reported its safety and efficacy for treating unresectable HCC in such case...

The most common non-surgical approaches for the treatment of localized hepatocellular carcinoma remain hepatic artery-delivered particles laden with chemotherapy (TACE), or radioactive microparticles (TARE). External beam radiotherapy has been an effective option in many parts of the world for selected HCC patients, but now has an expanded role with stereotactic and proton beam technologies. Th...

Soft tissue tumors (STTs) include a range of benign and malignant originating from soft tissues. Transarterial percutaneous therapies are image-guided minimally invasive approaches for managing primary metastatic STTs. The objective this review is to discuss transarterial by examining the current literature, including indications, patient selection, safety, effectiveness. (e.g., bland embolizat...